维普中文期刊产品整合服务
5篇 您的检索式:作者名="Gaojun Teng"
    题名 作者 年代 出处 被引量
1Consensus among Chinese experts on standard interventional therapy for deep venous thrombosis of lower extremity(second edition)显示文摘This is an update on the first edition of the expert consensus. This document discusses the indications and contraindications of interventional treatment methods for deep venous thrombosis such as anticoagulation, catheter-directed thrombolysis, percutaneous mechanical thrombectomy, percutaneous transluminal angioplasty and stent implantation. The operational procedures, considerations, preoperative management, and prevention of complications were also updated, supplemented, and revised. Emphasis is placed on the interventional treatment of acute and subacute deep venous thrombosis to effectively reduce the incidence of post-thrombosis syndrome.Jianping Gu Ke Xu Gaojun Teng 2018Journal of Interventional Medicine2018,1,3:16
2Chinese expert consensus on conversion therapy for hepatocellular carcinoma(2021 edition)显示文摘Recent advances in systemic and locoregional treatments for patients with unresectable or advanced hepatocellular carcinoma(HCC)have resulted in improved response rates.This has provided an opportunity for selected patients with initially unresectable HCC to achieve adequate tumor downstaging to undergo surgical resection,a‘conversion therapy’strategy.However,conversion therapy is a new approach to the treatment of HCC and its practice and treatment protocols are still being developed.Review the evidence for conversion therapy in HCC and develop consensus statements to guide clinical practice.Evidence review:Many research centers in China have accumulated significant experience implementing HCC conversion therapy.Preliminary findings and data have shown that conversion therapy represents an important strategy to maximize the survival of selected patients with intermediate stage to advanced HCC;however,there are still many urgent clinical and scientific challenges for this therapeutic strategy and its related fields.In order to summarize and learn from past experience and review current challenges,the Chinese Expert Consensus on Conversion Therapy for Hepatocellular Carcinoma(2021 Edition)was developed based on a review of preliminary experience and clinical data from Chinese and non-Chinese studies in this field and combined with recommendations for clinical practice.Sixteen consensus statements on the implementation of conversion therapy for HCC were developed.The statements generated in this review are based on a review of clinical evidence and real clinical experience and will help guide future progress in conversion therapy for patients with HCC.Hui-Chuan Sun Jian Zhou Zheng Wang Xiufeng Liu Qing Xie Weidong Jia Ming Zhao Xinyu Bi Gong Li Xueli Bai Yuan Ji Li Xu Xiao-Dong Zhu Dousheng Bai Yajin Chen Yongjun Chen Chaoliu Dai Rongping Guo Wenzhi Guo Chunyi Hao Tao Huang Zhiyong Huang Deyu Li Gang Li Tao Li Xiangcheng Li Guangming Li Xiao Liang Jingfeng Liu Fubao Liu Shichun Lu Zheng Lu Weifu Lv Yilei Mao Guoliang Shao Yinghong Shi Tianqiang Song Guang Tan Yunqiang Tang Kaishan Tao Chidan Wan Guangyi Wang Lu Wang Shunxiang Wang Tianfu Wen Baocai Xing Bangde Xiang Sheng Yan Dinghua Yang Guowen Yin Tao Yin Zhenyu Yin Zhengping Yu Bixiang Zhang Jialin Zhang Shuijun Zhang Ti Zhang Yamin Zhang Yubao Zhang Aibin Zhang Haitao Zhao Ledu Zhou Wu Zhang Zhenyu Zhu Shukui Qin Feng Shen Xiujun Cai Gaojun Teng Jianqiang Cai Minshan Chen Qiang Li Lianxin Liu Weilin Wang Tingbo Liang Jiahong Dong Xiaoping Chen Xuehao Wang Shusen Zheng Jia Fan 2022Hepatobiliary Surgery and Nutrition2022,11,2:4
3Study on the optimal concentration of topical mitomycin-C in preventing postlaminectomy epidural adhesion显示文摘Changhui Su Changjiang Yao Shenghua Lu Ailiang Zhang Xiaojian Cao Gaojun Teng Fengchao Zang 2010European Journal of Pharmacology2010,,1:1
4Magnetic Resonance Imaging of Acute Reperfused Myocardial Infarction: Intraindividual Comparison of ECIII-60 and Gd-DTPA in a Swine Model显示文摘Jiyang Jin Gaojun Teng Yi Feng Yanping Wu Qindi Jin Yu Wang Zhen Wang Qin Lu Yibo Jiang Shengqi Wang Feng Chen Guy Marchal Yicheng Ni 2007CardioVascular and Interventional Radiology2007,,2:1
5Clinical Effects of Treatment for Lung Cancer with Double Points Cryoablation through Percutaneous Puncture Guided by Computed Tomography显示文摘OBJECTIVE To investigate the clinical effects of the applicationof double points cryoablation through percutaneous puncture foradvanced lung cancer patients.METHODS Forty-one patients diagnosed with stage Ⅲ-Ⅳpulmonary carcinoma were selected for the study.The patientswere found to have from 1 to 3 foci of carcinoma,and in eachcase the disease was limited to one lung.The study patients weredivided randomly into 3 groups.There were 16 cases receivingroutine chemotherapy and radiotherapy in group Ⅰ,13 casestreated with cryoablation at a single point in group Ⅱ,and 12 casestreated with cryoablation at 2 points simultaneously in group Ⅲ.The patients in the 2 cryoablation groups also received the sametreatment as the patients did in group Ⅰ.The clinical effects wereevaluated within 6 months after treatment,and the survival ratewas followed-up for 3 years.RESULTS The clinical effects were improved significantly aftertreatment in group Ⅱ and in group Ⅲ compared with those ingroup Ⅰ (P<0.05),including an enhanced regressive rate of 21%,postponed tumor progression of 50.58% and a clinical benefit rateof 92%.The effective rate of regression in group Ⅲ was higherthan that in group Ⅱ,43.59% (P<0.05),and the 3-year survival ratewas 37.25%.Significant differences in side effects were not foundbetween the 2 cryoablation groups.CONCLUSION Cryosurgery ablation at 2 points,simultaneously,and directed at 1 foci might improve the effects oftreatment and the prognosis of lung cancer patients,when used incombination with routine treatment.Zao Jiang Gaojun Teng Wen Fang Xiaoyi Gu Guozhao Li 2009Clinical oncology and cancer resexreh2009,6,5:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费